Jeremy Irons | A message from Jeremy Irons, Patron of The Greater Chernobyl Cause. | By The Greater Chernobyl Cause | Facebook
![Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda](https://journals.sagepub.com/cms/10.1177/1352458517707345/asset/images/large/10.1177_1352458517707345-fig4.jpeg)
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda
![Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ... Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b00392/asset/images/large/jm-2018-003925_0009.jpeg)
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ...
![INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology | ACS Medicinal Chemistry Letters INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.6b00391/asset/images/large/ml-2016-00391h_0001.jpeg)
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology | ACS Medicinal Chemistry Letters
![Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda](https://journals.sagepub.com/cms/10.1177/1352458517707345/asset/images/large/10.1177_1352458517707345-fig1.jpeg)
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda
![Interim monitoring using the adaptively weighted log‐rank test in clinical trials for survival outcomes - Yang - 2019 - Statistics in Medicine - Wiley Online Library Interim monitoring using the adaptively weighted log‐rank test in clinical trials for survival outcomes - Yang - 2019 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/28f5d941-6053-4d60-a422-280ed26de11f/sim.v38.4.cover.jpg)
Interim monitoring using the adaptively weighted log‐rank test in clinical trials for survival outcomes - Yang - 2019 - Statistics in Medicine - Wiley Online Library
![Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives | Journal of Medicinal Chemistry Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01093/asset/images/large/jm0c01093_0009.jpeg)
Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives | Journal of Medicinal Chemistry
![The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma in: European Journal of Endocrinology Volume 178 Issue 2 (2018) The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma in: European Journal of Endocrinology Volume 178 Issue 2 (2018)](https://eje.bioscientifica.com/view/journals/eje/178/2/images/EJE-17-0810fig2.jpeg)
The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma in: European Journal of Endocrinology Volume 178 Issue 2 (2018)
![Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets | Journal of Medicinal Chemistry Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01694/asset/images/large/jm1c01694_0001.jpeg)
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets | Journal of Medicinal Chemistry
![Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial - The Lancet Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/46a11b47-b14c-4e31-8358-9335eb4bbe68/gr1_lrg.gif)